Aurinia Pharmaceuticals Inc (AUPH)

[Whalatane]

This will not go to 0 (if there is no deal )
Lupkynis is an important new drug that will slow progression to dialysis for CKD patients with severe LN .

If BP and AUPH can not come to terms then AUPH will GIA and experience a cash drain in the first year or so … but Lupkynis will eventually be used by many with severe LN because it’s cost effective re dialysis costs ( $120k a yr ) … let alone what life is like for dialysis patients —- up to 4 hrs a day ,3 days a week on a machine cleaning your blood .

Am I the only one here who has actually been on a dialysis floor ?

Kiwi